BB Biotech AG 13D/13G Filings for Annexon, Inc. (ANNX)

BB Biotech AG 13D and 13G filings for Annexon, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
7:21 pm
Purchase
2024-09-3013GAnnexon, Inc.
ANNX
BB Biotech AG5,157,290
4.900%
475,000increase
(+10.14%)
Filing
2024-04-22
8:35 pm
Purchase
2024-04-1713GAnnexon, Inc.
ANNX
BB Biotech AG4,682,290
5.200%
4,682,290increase
(New Position)
Filing